Time: March 27, 2017 from 1:30pm to 2:30pm
Location: Online Webinar - Eastern Time Zone
Website or Map: https://www.readytalk.com/join
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Mar 23
Monday, March 27 at 1:30 PM EST
Please join Parent Project Muscular Dystrophy and Akashi Therapeutics as we host a webinar Monday, March 27 at 1:30 PM ET to discuss HT-100 and next steps for the clinical program.
Akashi CEO Marc Blaustein will present data from the previous clinical program of HT-100 and discuss FDA’s recent decision to allow the clinical development of HT-100 to resume, and leave time for discussion and fielding of questions.
Please submit questions in advance to email@example.com, with “Akashi Webinar” in the subject line by Friday, March 24th at 5pm eastern.